HUTCHMED (China) (HCM) Cash from Financing Activities (2018 - 2021)

HUTCHMED (China)'s (HCM) quarterly Cash from Financing Activities came in at $605.1 million in Q2 2021, up 4315.1% year-on-year from $13.7 million in Q2 2020, and up 2362.23% on a QoQ basis from -$26.7 million in Q1 2021.

HUTCHMED (China) (HCM) Cash from Financing Activities (2018 - 2021) Analysis & Trends

HUTCHMED (China) (HCM) has 4 years of Cash from Financing Activities data on file, last reported at $605.1 million in Q2 2021.

  • On a quarterly basis, Cash from Financing Activities rose 4315.1% year-over-year to $605.1 million in Q2 2021; TTM through Jun 2021 was $674.7 million, a 442.5% increase from a year earlier, with the FY2025 full-year figure at $7.8 million, up 125.55% from the prior year.
  • Cash from Financing Activities for Q2 2021 stood at $605.1 million, up from -$26.7 million in the prior quarter.
  • Over the last five years, Cash from Financing Activities for HCM reached as high as $605.1 million in Q2 2021 and fell as low as -$29.2 million in Q2 2019.
  • Historically, Cash from Financing Activities has averaged $56.8 million across 4 years, with a median of -$161000.0 in 2018.
  • Across the five-year window, Cash from Financing Activities plunged 1017.16% in 2019 and surged 32093.64% in 2020, its largest moves.
  • Year by year, Cash from Financing Activities stood at $16.0 million in 2018, then soared by 67.63% to $26.9 million in 2019, then tumbled by 153.36% to -$14.4 million in 2020, then soared by 4315.1% to $605.1 million in 2021.
  • Per Business Quant data, the three most recent Cash from Financing Activities figures were $605.1 million in Q2 2021, -$26.7 million in Q1 2021, and -$14.4 million in Q2 2020.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash from Financing Activities (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 13.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -840.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -494.13 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -1.48 Bn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -203.80 Mn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -86.10 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -65.00 Mn
10 HUTCHMED (China) 241.90 Mn 243.61 Mn - -

Historic Data

Download Data
DateValue
Jun 30, 2021 605.08 Mn
Jun 30, 2021 605.08 Mn
Mar 31, 2021 -26.75 Mn
Mar 31, 2021 -26.75 Mn
Jun 30, 2020 -14.36 Mn
Jun 30, 2020 -14.36 Mn
Mar 31, 2020 110.70 Mn
Mar 31, 2020 110.70 Mn
Dec 31, 2019 26.90 Mn
Dec 31, 2019 26.90 Mn
Sep 30, 2019 1.12 Mn
Sep 30, 2019 1.12 Mn
Jun 30, 2019 -29.17 Mn
Jun 30, 2019 -29.17 Mn
Mar 31, 2019 -346,000.00
Mar 31, 2019 -346,000.00
Dec 31, 2018 16.05 Mn
Dec 31, 2018 16.05 Mn
Sep 30, 2018 24,000.00
Sep 30, 2018 24,000.00